Characterization of Ca(2+)-inhibited potassium channels in the LNCaP human prostate cancer cell line

Recept Channels. 1999;6(4):241-53.

Abstract

Potassium plasma membrane channels have been studied in the LNCaP androgen-sensitive human prostate cancer cell line, derived from a lymph node of a subject with metastatic carcinoma of the prostate. Membrane currents were recorded by the patchclamp technique, using the cell-attached, cell-free and whole-cell mode. A voltage-dependent, non-inactivating potassium channel (delayed rectifier) was the most commonly observed ion channel in LNCaP cells. The slope conductance of K+ channels in a symmetrical 140 mM K+ gradient was 78 pS. In excised inside-out patches, the channel was inhibited by increasing the cytoplasmic Ca2+ concentration (with half-block at 0.5 microM Ca2+) over a wide range of membrane potentials. The K+ channel had a high sensitivity to tetraethylammonium (TEA), that reduced the single channel conductance with Kd of 280 +/- 27 microM. The K+ channel open probability was inhibited by alpha-dendrotoxin (DTX) (with a half-blocking concentration of approximately 5 nM) and mast cell degranulating peptide (MCDP) (with half-blocking concentration of approximately 70 nM) at all membrane potentials and with very slow reversibility. In view of the biophysical and pharmacological properties of K+ channels in LNCaP cells, it is not possible to classify these channels as one of the previously characterized types of voltage- or ligand-gated K+ channels in other cell lines.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adenocarcinoma / secondary*
  • Calcium / pharmacology*
  • Charybdotoxin / pharmacology
  • Elapid Venoms / pharmacology
  • Humans
  • Ion Channel Gating / drug effects*
  • Ion Transport / drug effects
  • Lymphatic Metastasis / pathology*
  • Male
  • Neoplasm Proteins / antagonists & inhibitors*
  • Neoplasms, Hormone-Dependent / pathology*
  • Patch-Clamp Techniques
  • Peptides / pharmacology
  • Potassium Channel Blockers*
  • Prostatic Neoplasms / pathology*
  • Quinidine / pharmacology
  • Tetraethylammonium / pharmacology
  • Tumor Cells, Cultured

Substances

  • Elapid Venoms
  • Neoplasm Proteins
  • Peptides
  • Potassium Channel Blockers
  • Charybdotoxin
  • mast cell degranulating peptide
  • Tetraethylammonium
  • dendrotoxin
  • iberiotoxin
  • Quinidine
  • Calcium